0
0
0
Pharmacy Benefit Manager Transparency Act of 2025
3/12/2025, 4:29 PM
Summary of Bill S 526
Bill 119 s 526, also known as the "Pharmacy Benefit Manager Transparency Act," aims to address issues related to pharmacy benefit management services for prescription drugs. The bill seeks to prevent unfair and deceptive acts or practices, as well as the dissemination of false information in this industry.
The main goal of the bill is to increase transparency and accountability within the pharmacy benefit management sector. This includes requiring pharmacy benefit managers to disclose information about their pricing practices, rebates, and any potential conflicts of interest. By doing so, the bill aims to ensure that consumers have access to accurate and reliable information when it comes to their prescription drug coverage.
Additionally, the bill includes provisions to protect consumers from being misled or deceived by pharmacy benefit managers. This includes prohibiting practices that could result in higher costs for consumers or limit their access to necessary medications. Overall, Bill 119 s 526 seeks to promote fairness and honesty within the pharmacy benefit management industry, ultimately benefiting consumers and ensuring that they receive the best possible care when it comes to their prescription drug coverage.
The main goal of the bill is to increase transparency and accountability within the pharmacy benefit management sector. This includes requiring pharmacy benefit managers to disclose information about their pricing practices, rebates, and any potential conflicts of interest. By doing so, the bill aims to ensure that consumers have access to accurate and reliable information when it comes to their prescription drug coverage.
Additionally, the bill includes provisions to protect consumers from being misled or deceived by pharmacy benefit managers. This includes prohibiting practices that could result in higher costs for consumers or limit their access to necessary medications. Overall, Bill 119 s 526 seeks to promote fairness and honesty within the pharmacy benefit management industry, ultimately benefiting consumers and ensuring that they receive the best possible care when it comes to their prescription drug coverage.
Read the Full Bill
Current Status of Bill S 526
Bill S 526 is currently in the status of Bill Introduced since February 11, 2025. Bill S 526 was introduced during Congress 119 and was introduced to the Senate on February 11, 2025. Bill S 526's most recent activity was Read twice and referred to the Committee on Commerce, Science, and Transportation. as of February 11, 2025
Bipartisan Support of Bill S 526
Total Number of Sponsors
4Democrat Sponsors
0Republican Sponsors
4Unaffiliated Sponsors
0Total Number of Cosponsors
23Democrat Cosponsors
8Republican Cosponsors
15Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 526
Primary Policy Focus
HealthAlternate Title(s) of Bill S 526
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Comments
Sponsors and Cosponsors of S 526
Latest Bills
Community Bank Representation Act
Bill HR 6554March 10, 2026
Gateway Partnership Act
Bill HR 5254March 10, 2026
Merger Agreement Approvals Clarity and Predictability Act
Bill HR 6570March 10, 2026
Enhancing Bank Resolution Participation Act
Bill HR 6555March 10, 2026
Muhammad Ali American Boxing Revival Act of 2026
Bill HR 4624March 10, 2026
New BANK Act of 2025
Bill HR 6551March 10, 2026
SHARKED Act of 2025
Bill S 2314March 10, 2026
TIER Act of 2025
Bill HR 6553March 10, 2026
Save Our Shrimpers Act
Bill HR 2071March 10, 2026
Restoring the Secondary Trading Market Act
Bill HR 7127March 10, 2026





